Interacting Drugs |
Rosiglitazone and glimepiride vs Corticosteroids (Orally Inhaled) |
Security Level |
|
Mechanism |
Corticosteroids (Orally Inhaled): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use. |
Management |
Monitor therapy |
Rosiglitazone and glimepiride vs Corticosteroids (Orally Inhaled)
Post Review about Rosiglitazone and glimepiride vs Corticosteroids (Orally Inhaled) Click here to cancel reply.
Other Interactions of Corticosteroids (Orally Inhaled)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.